CTLA4 and acute myeloid leukemia: We used detection of PTPRC exon 4 in two cases of AML (AML1007, AML3005) following CTLA-4 blockade and observed reduced expression across T cell subsets, consistent with known T cell differentiation induced by ipilimumab (Fig. 8c, Supplementary Fig. 14c)37.